Healthcare [ 13/13 ] | Medical Devices [ 113/164 ]
NASDAQ | Common Stock
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.
The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force.
ProSomnus, Inc. is headquartered in Pleasanton, California.
On May 7, 2024, ProSomnus, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S.
Bankruptcy Court for the District of Delaware.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 26, 24 | -0.42 Decreased by -3.22 K% | -0.31 Decreased by -34.71% |
| Nov 10, 23 | -0.70 Decreased by -116.13 K% | - |
| Aug 3, 23 | -0.01 Increased by +33.17% | - |
| May 10, 23 | -0.43 Decreased by -2.04 K% | - |
| Sep 30, 22 | 0.01 Increased by +194.37% | - |
| Jun 30, 22 | -0.00 | - |
| Mar 31, 22 | -0.02 | - |
| Dec 31, 21 | -0.02 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 7.84 M - | -6.87 M - | Decreased by -87.63% - |
| Sep 30, 23 | 7.07 M - | -11.24 M - | Decreased by -158.93% - |
| Jun 30, 23 | 6.93 M - | 904.93 K - | Increased by +13.05% - |
| Mar 31, 23 | 5.81 M - | -6.89 M - | Decreased by -118.66% - |